Status:
RECRUITING
KIDney Injury in Times of COVID-19 (KIDCOV)
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Rush University Medical Center
University of Michigan
Conditions:
SARS-CoV Infection
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture t...
Detailed Description
KIDCOV is a longitudinal cohort study that will prospectively follow cohorts of COVID19-negative and COVID19-positive adults for episodes of kidney injury over a 12-months period. Study candidates wil...
Eligibility Criteria
Inclusion
- Result of PCR-based COVID-19 test conducted in the past 4 weeks posted in EMR of participating AMC
- Age 18 years or older at enrollment
- Race/ethnicity, sex, age, and phone and/or home/email address provided
Exclusion
- Failure of a candidate participant to give written informed consent to comply with the study protocol
- Hospitalization up to 4 weeks after SARS-CoV-2 test
- History of kidney transplant
- History of dialysis
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04705766
Start Date
March 1 2021
End Date
March 1 2027
Last Update
July 28 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF
San Francisco, California, United States, 94143
2
Rush University
Chicago, Illinois, United States, 60612
3
University of Michigan
Ann Arbor, Michigan, United States, 48109